A major direction for future microbiome research is implementation of fecal sample collections in large-scale, prospective epidemiologic studies. Studying microbiome-disease associations likely requires microbial data to be pooled from multiple studies. Our findings suggest collection methods that are most optimal to be used standardly across future WGSS microbiome studies.
KEYWORDS: whole-genome shotgun sequencing, microbiome, fecal sample collection method, FOBT cards, FIT tubes
ABSTRACT
Few previous studies have assessed stability and “gold-standard” concordance of fecal sample collection methods for whole-genome shotgun metagenomic sequencing (WGSS), an increasingly popular method for studying the gut microbiome. We used WGSS data to investigate ambient temperature stability and putative gold-standard concordance of microbial profiles in fecal samples collected and stored using fecal occult blood test (FOBT) cards, fecal immunochemical test (FIT) tubes, 95% ethanol, or RNAlater. Among 15 Mayo Clinic employees, for each collection method, we calculated intraclass correlation coefficients (ICCs) to estimate stability of fecal microbial profiles after storage for 4 days at ambient temperature and concordance with immediately frozen, no-solution samples (i.e., the putative gold standard). ICCs were estimated for multiple metrics, including relative abundances of select phyla, species, KEGG k-genes (representing any coding sequence that had >70% identity and >70% query coverage with respect to a known KEGG ortholog), KEGG modules, and KEGG pathways; species and k-gene alpha diversity; and Bray-Curtis and Jaccard species beta diversity. ICCs for microbial profile stability were excellent (≥90%) for fecal samples collected via most of the collection methods, except those preserved in 95% ethanol. Concordance with the immediately frozen, no-solution samples varied for all collection methods, but the number of observed species and the beta diversity metrics tended to have higher concordance than other metrics. Our findings, taken together with previous studies and feasibility considerations, indicated that FOBT cards, FIT tubes, and RNAlater are acceptable choices for fecal sample collection methods in future WGSS studies.
IMPORTANCE A major direction for future microbiome research is implementation of fecal sample collections in large-scale, prospective epidemiologic studies. Studying microbiome-disease associations likely requires microbial data to be pooled from multiple studies. Our findings suggest collection methods that are most optimal to be used standardly across future WGSS microbiome studies.
INTRODUCTION
Growing evidence suggests that the gut microbiome is involved in the etiology of multiple chronic diseases, including certain cancers (1–6). However, vast gaps in knowledge exist regarding microbiome-disease associations, exacerbated by inconsistent findings across studies which may be due, in part, to differences in fecal sample collection and storage, DNA extraction and amplification, bioinformatic procedures, and other factors (7, 8).
A major direction for future microbiome research is implementation of fecal sample collections in large-scale, prospective epidemiologic studies. Evidence from 16S rRNA gene amplicon sequencing studies suggests that the chosen fecal collection method impacts multiple estimates of microbial composition (9–12); thus, development of standard fecal collection protocols is required, especially for pooling of microbial data across studies. Ideal fecal sample collection methods preserve the original microbial signature of the fecal sample, stabilize microbial DNA, and prevent bacterial growth during room-temperature storage for multiple days, which is typical under field conditions (10, 13–16).
While 16S rRNA gene amplicon sequencing is commonly used to characterize bacterial profiles, researchers are increasingly using whole-genome shotgun metagenomic sequencing (WGSS) to sequence the genome of all microorganisms in biological samples. Compared to 16S rRNA gene studies, WGSS provides high-resolution profiles of bacteria down to the species or strain level and can estimate functional potential of microbes using gene/pathway content information, which may be particularly important for understanding the role of the microbiota in human health (17–19).
Only one small study (n = 8) (20) investigated stability and “gold-standard” concordance of WGSS fecal samples, collected using 100% ethanol or RNAlater. That study did not consider other common, established methods for fecal sample collection such as fecal occult blood test (FOBT) cards and fecal immunochemical tests (FIT), which were recently shown to be reproducible, stable, and relatively concordant with the “gold-standard” collection method in 16S rRNA gene studies (10–12). FOBT cards and FIT tests are used widely in colorectal cancer screening, providing opportunities for establishing prospective cohorts using discarded tests. We used WGSS to comprehensively characterize the microbiota of fecal samples in a subset (n = 15) of individuals from a previous 16S rRNA gene sequencing study, the Mayo 2 study (11). Here, we report an investigation of the stability and “gold-standard” concordance of the WGSS profiles in fecal samples collected using four methods: FOBT cards, FIT tubes, 95% ethanol, and RNAlater.
RESULTS
Participants predominantly were non-Hispanic white (86.7%), had a bowel movement at least once per day (80.0%), and were nonsmokers (100%). About half were female (53.3%). On average, they were 37.5 years old, with ages ranging from 22 to 53 (see Table S1 in the supplemental material).
Alpha diversity by collection method.
As shown in Fig. 1, the number of observed species and the Shannon index values for species were generally highest in samples without solution, frozen on day-0 (the “gold standard”). The number of observed k-genes (representing any coding sequence that had >70% identity and >70% query coverage with respect to a known KEGG ortholog) and the Shannon index values for k-genes tended to be higher on day-0 of freezing, except in RNAlater samples, and were highest, on average, in FOBT card samples for both metrics. After adjusting for freezing time in linear mixed-effects models (Table S2), compared to the “gold standard,” averages of 46, 31, 41, and 43 fewer species were detected in samples collected via 95% ethanol, FIT tubes, FOBT cards, and RNAlater, respectively (P = 0.001, 0.02, 0.002, and 0.001, respectively). In RNAlater samples, the Shannon index values for species and the number of observed k-genes were lower than were seen with the “gold standard,” and the Shannon index value for k-genes was highest in FOBT card samples compared to all other samples.
Percent variability explained by subject, collection method, and storage time.
Based on the Bray-Curtis and Jaccard distance matrices, the percentage of variability in species and k-genes was primarily explained by subject and minimally by collection method and storage time (see Fig. S1 in the supplemental material; see also Table S3). For example, based on the Bray-Curtis distance matrix, interindividual variability explained 71% and 68% of variability in species and k-genes, respectively; whereas the collection method explained 9% and 10%, respectively; and storage time explained <1% of variability for both metrics.
Relative abundance comparisons.
As shown in Fig. 2 (and in Fig. S2, by sample), samples collected without solution and frozen day-0 had relative abundances that were ≥2% of those calculated for certain species, such as Akkermansia muciniphila, Bifidobacterium longum, Blautia obeum, Blautia sp. KLE 1732, Collinsella sp. 4_8_47FAA, and Streptococcus thermophilus, that were not detected at abundances of ≥2% by the other collection methods similarly frozen day-0. For the other collection methods, the general distributions of relative abundances of each species were fairly inconsistent, but the differences between those methods were smaller than those seen with the samples without solution.
Stability.
Intraclass correlation coefficients (ICCs) comparing fecal samples frozen day-4 to those frozen day-0 by collection method are shown in Fig. 3 (exact ICCs and 95% confidence intervals [CIs] are listed in Table S4). Stability ICCs for the most dominant phyla, alpha diversity of species and k-genes, and the first two principal coordinates of Bray-Curtis and Jaccard distance matrices for species were mostly ≥90% in samples collected using the FIT, FOBT, and RNAlater collection methods. Stability ICCs were generally lower and more variable in samples collected using 95% ethanol.
Stability ICCs for the most abundant species, k-genes, modules, and pathways are shown in Fig. 4 (exact ICCs and 95% confidence intervals are listed in Table S5) for each collection method. Similarly to the diversity metrics, ICCs for samples collected using FOBT, FIT, and RNAlater were generally higher than those for 95% ethanol samples. In the 95% ethanol samples, 4 of 20 species, 3 of 20 k-genes, 2 of 10 modules, and 3 of 10 pathways had ICCs representing poor (<40%) stability. There were no substantial differences in the stability ICCs calculated based on the centered log ratio-transformed and untransformed relative abundances (data not shown), except that the ICCs for centered log ratio-transformed pathways were generally lower.
Concordance.
ICCs comparing samples without solution frozen on day-0 (i.e., the putative “gold standard”) to samples collected using the other methods (also frozen day-0) are shown in Fig. 5 (exact ICCs, the corresponding calculated Spearman correlations [SCCs], and their 95% CIs are listed in Table S6). Generally, the confidence intervals were wide, indicating high variability in “gold-standard” concordance. ICCs were lowest for samples collected using 95% ethanol and FOBT cards for relative abundance of Actinobacteria (0.46 and 0.30, respectively), Bacteroidetes (0.23 and 0.36, respectively), and Firmicutes (0.33 and 0.40, respectively); whereas for FIT tubes and RNAlater, the corresponding ICCs were >0.50. ICCs for observed species were ≥75% for all collection methods. For the rest of the alpha diversity metrics, ICCs were generally highest in FOBT and RNAlater samples and lowest in 95% ethanol samples. ICCs were ≥75% for the first principal-coordinate vectors of both species Bray-Curtis and Jaccard distances for all collection methods, except for 95% ethanol samples with slightly lower ICCs, but for all collection methods, ICCs were substantially lower for the second principal-coordinate vector of both distance matrices (i.e., all ICCs were <40%, except in RNAlater samples). Spearman correlations (SCCs) (Table S6) comparing the rank order of each metagenomic diversity metric to those for the “gold standard” varied between being slightly higher or lower than the ICCs.
Concordance ICCs for the most abundant species, k-genes, modules, and pathways are shown in Fig. 6 and listed in Table S7 (along with corresponding SCCs) for each fecal sample collection method. Seven, six, five, and three of the 20 most abundant species had poor concordance ICCs in 95% ethanol, FIT tubes, FOBT cards, and RNAlater samples, respectively. Concordance ICCs for k-genes, modules, and pathways varied greatly (e.g., range of concordance ICCs for k-genes in FOBT and RNAlater samples, 0.06 to 0.81 and 0.06 to 0.91, respectively), and occurrences of ICCs that were <40% were frequent across all methods; however, the 95% ethanol samples tended to have the highest proportion of metrics with ICC estimates of <40%. Concordance ICCs calculated based on the centered log ratio-transformed and untransformed relative abundances varied between being higher or lower than those calculated based on the square root abundances, except that the ICCs for centered log ratio-transformed species tended to be much higher (data not shown). Finally, concordance ICCs for the microbiome metrics for each pairwise comparison of the collection methods varied greatly but were generally >40%. ICCs were highest comparing FOBT cards and RNAlater (Table S8).
DISCUSSION
In this study of the stability and “gold-standard” concordance of WGSS profiles of fecal samples collected using FOBT cards, FIT tubes, RNAlater, and 95% ethanol, our results support the conclusions that (i) the variation in WGSS profiles is primarily explained by interindividual differences and substantially less so by collection method or days of storage at ambient temperature; (ii) the distribution of species-level relative abundances differ across collection methods, particularly so for samples collected, frozen, and thawed without solution; (iii) all collection methods, except for 95% ethanol, adequately preserved WGSS bacterial profiles after 4 days at ambient temperature; and (iv) compared to immediate freezing of no-solution samples, all collection methods tended to be most concordant for the observed species and the first principal-coordinate vectors for Bray-Curtis or Jaccard species distances.
The stability and “gold-standard” concordance of microbial profiles of fecal samples collected via the different methods were most extensively characterized using 16S rRNA gene sequencing (10–12, 21–25). Only one WGSS study, by Franzosa et al. (20), previously investigated the short-term stability and “gold-standard” concordance of fecal samples collected using RNAlater or 100% ethanol. After 2 days of storage at room temperature, they found that both methods preserved metagenomic profiles of fecal samples (similarly to our RNAlater findings) and that the results seen with both methods were comparable to those seen with the method employing immediately frozen samples without solution. Previously, Vogtmann et al. investigated the stability and accuracy of sequencing of 16S rRNA gene amplicon bacterial profiles of fecal samples collected via FOBT cards, FIT tubes, 95% ethanol, and RNAlater in the larger Mayo 2 study (n = 52) in which this study was nested (11). In analogy to our findings, they found that interindividual differences explained most variability in bacterial profiles and that, for the microbiome diversity metrics (comprising three phyla, alpha diversity metrics, and beta diversity metrics), the method employing 95% ethanol was generally the least stable of all the fecal sample collection methods.
While 95% ethanol was the only collection method seemingly unsuitable for storage of fecal samples at ambient temperature, no collection method was more suitably concordant with the “gold standard” than any other. Due to the nature of storage without solution (e.g., in the absence of DNA stabilizing or antimicrobial agents), growth of certain taxa is highly plausible (26), especially during freezing or thawing performed for extraction and sequencing or under typical field conditions where participants collect their own fecal samples at home and ship them to laboratories (10, 14). Therefore, though the use of immediately frozen samples without solution is considered the “gold standard” in the field (8, 23, 27–29), it is difficult to ascertain whether the results seen with the no-solution samples in this study could be confirmed as representative of the “truth”—a feat that would truly be possible only with immediate DNA extraction after defecation. Of concern, we observed greater relative abundances of certain species in no-solution samples than were seen with the other collection methods, similarly to an occurrence in a study by Bahl et al., which found that, compared to immediately extracted samples, samples that were frozen without solution differed in their Firmicutes-to-Bacteroidetes ratio (30). Since the relative abundance estimates were highly interrelated due to their compositionality, if bacterial growth occurred in the no-solution samples, our concordance estimates for all relative abundances would most likely be lower than the truth. This may be further evidenced by the higher concordance ICCs that we observed for centered log ratio-transformed species relative abundance (compared to square root-transformed abundance), which incorporate methods developed to account for relative abundance interrelatedness (31). Thus, taken together, our “concordance” findings should be interpreted with caution.
This study had several strengths. This was the first study to use WGSS to estimate the stability and concordance of bacteria in samples collected using four different methods. These collection methods were also shown to be generally stable and “gold-standard” concordant in 16S rRNA gene sequencing analyses of bacteria (10–12); most of these methods can be used for other -omics technologies, except for RNAlater, which cannot be used for metabolomics (21, 32); and FOBT cards and FIT tubes are cost-effective options that are increasingly used for colorectal cancer screening, opening opportunities for establishing prospective cohorts within screening populations. Furthermore, each collection method has its own advantages pertaining to stabilizing DNA, preventing bacterial growth, and preserving microbial profiles that are as close to those of the original sample as possible. For example, FIT tubes stabilize DNA via the use of antimicrobial agents (e.g., sodium azide) (8, 24); 95% to 99% ethanol has antimicrobial properties (8); and RNAlater acts as both a DNA stabilizer and an RNA stabilizer by preventing degradation by nucleases (33).
This study also had several limitations. This study was conducted in a mostly white, healthy population, which may limit generalizability with respect to populations with different environmental exposures; however, we previously found, using 16S rRNA gene amplicon sequencing data, that the levels of stability and “gold-standard” concordance of each fecal sample collection method were similar between populations in the United States and in Bangladesh (11, 12). Furthermore, in this study, stability was assessed only over the course of 4 days at ambient temperature, which may not necessarily directly reflect shipping conditions (which, e.g., might involve longer shipping times or storage in higher temperatures) and also does not necessarily reflect storage in freezers over long periods of time. Voigt et al. investigated long-term stability of WGSS profiles in fecal samples stored in RNAlater (n = 7) (34) and found that RNAlater preserved the microbiota composition well for up to 2 years of storage at –80°C. These findings warrant future studies of long-term stability using the collection methods described here.
Conclusion.
These findings, taken together with previous 16S rRNA gene and other -omic stability and concordance studies, indicate that FOBT cards, FIT tubes, and RNAlater may be appropriate choices to collect fecal samples for WGSS in future studies, as these options are stable after storage at ambient temperature. Given the large gaps in knowledge pertaining to the role of the gut microbiome in the etiology of health and disease, ideally, one method should be used as the standard across studies so that WGSS data may be pooled to improve power to detect bacterial species/gene-level exposure/disease associations. Future studies should further investigate the long-term (over the course of years) stability of these collection methods in WGSS studies and should continue to explore the stability and concordance of each fecal collection method for other -omics technologies.
MATERIALS AND METHODS
Study population.
The Mayo 2 study was described previously (11). Briefly, among Mayo Clinic employees in Rochester, MN, 52 healthy volunteers were recruited and 15 participants from that group were randomly selected for this study. Eligible individuals were ≥18 years old, had not used antibiotics or probiotics within the 2 weeks prior, had no history of pelvic radiation, and were not receiving concurrent chemotherapy treatment. All participants gave informed consent, and the study was approved by the Mayo Clinic Studies Institutional Review Board.
Data collection.
Each participant was provided an Exakt Pak canister (Inmark Packaging, Austell, GA) to collect feces. After defecation, the sample was delivered to the laboratory for immediate processing by a study coordinator. Diet and medical history were assessed with abbreviated questionnaires.
For each participant, fecal specimens were manually mixed using a spatula, and aliquots of samples obtained using the four different collection methods plus one sample without solution were generated in random order. For each participant, approximately 1 to 2 g of feces was placed in a Sarstedt feces tube (Numbrecht, Germany) without solution (4 aliquots), with 2.5 ml of RNAlater stabilization solution (4 aliquots), or with 2.5 ml of 95% ethanol (Sigma-Aldrich, St. Louis, MO; 4 aliquots). Four triple-slide Hemoccult II Elite Dispensapak Plus for FOBT cards (Beckman Coulter, Brea, CA) were smeared thinly with feces, and the flap was closed per manufacturer instructions. Four FIT tube aliquots (Polymedco, Inc., Cortlandt Manor, NY) were created by dipping the probe into the fecal specimen, shaking the tube, and transferring the fluid from one FIT tube into two cryovials.
All replicates of the no-solution samples and half of the 95% ethanol, RNAlater, FOBT card, and FIT tube replicates were frozen immediately (−80°C; day-0). To simulate testing for occult blood in colorectal cancer screening, the FOBT cards were developed with 2 drops of Hemoccult Sensa Developer (Beckman Coulter) applied to the guaiac paper on the back of the card immediately prior to freezing. The remaining half of each sample was stored at ambient temperature for 4 days and then frozen at −80°C (day-4). For each participant, one immediately frozen no-solution sample and two replicates frozen on day-0 and day-4 for all other collection methods were submitted for WGSS (n = 135 samples plus 14 duplicates).
DNA extraction.
Fecal samples were submitted for WGSS in either solid or homogenized form or smeared onto FOBT cards. Homogenized stool samples (FIT tube, 95% ethanol, and RNAlater samples) were subjected to thorough vortex mixing, and 150 μl was aliquoted for DNA extraction. For solid stool (samples without solution), approximately 50 mg of sample was retrieved using a sterile spatula. For FOBT card smears, a squared area containing the majority of the stool was cut from the card. Then, all samples were transferred into a well on an extraction deep-well plate.
DNA extraction was conducted using a PowerMag soil DNA isolation kit (Mo Bio Laboratories, catalog no.27000-4) on a Hamilton STARlet automated liquid handler platform following the manufacturer’s instructions. DNA concentrations were estimated using the PicoGreen assay.
Metagenomic WGS.
DNA (100 ng) was sheared into fragments of approximately 300 to 400 bp in a Covaris E210 system (Covaris, Inc., Woburn, MA) (96-well format) followed by purification of the fragmented DNA by the use of AMPure XP beads. DNA end repair, 3′ adenylation, ligation to Illumina multiplexing PE adaptors, and ligation-mediated PCR (LM-PCR) were all completed using automated processes. Kapa HiFi polymerase (Kapa Biosystems Inc.) was used for PCR amplification (8 cycles), which is known to amplify high-GC-rich and low-AT-rich regions at greater efficiency. A Fragment Analyzer electrophoresis system (Advanced Analytical Technologies, Inc.) was used for library quantification and size estimation. Prepared libraries (consisting of fragments that were, on average, 373 bp in size, including adapter and barcode) were then pooled in equimolar amounts to reach a final concentration of 20 nM and an average of 11 samples per pool.
Library templates were prepared for sequencing using Illumina’s cBot cluster generation system with TruSeq PE cluster generation kits. Briefly, the library templates was denatured with sodium hydroxide and diluted to 7 pM in hybridization buffer in order to achieve an average load density of 819,000 clusters/mm2. Each library pool was loaded in a single lane of a HiSeq 2000 flow cell spiked with a 1% phiX control library for run quality control. The sample then underwent bridge amplification to form clonal clusters, followed by hybridization with the sequencing primer. Sequencing runs were performed in paired-end mode using an Illumina HiSeq 2000 platform. Using TruSeq SBS kits, sequencing-by-synthesis reactions were extended for 101 cycles from each end, with an additional 10 cycles for the index read. After sequencing, .bcl files were processed through Illumina’s analysis software (bcl2fastq), which demultiplexes pooled samples and generates sequence reads and base-call confidence values (qualities). The average raw sequence yield per sample was 4.1 gigabases. One sample failed sequencing (an FOBT card sample frozen day-4).
Metagenomic analysis.
Raw sequences were quality filtered and trimmed using a pipeline developed at the Baylor College of Medicine that employs a number of publicly available tools such as Casava v1.8.3 (Illumina) for the generation of fastqs and Trim Galore, PRINSEQ, and cutadapt for adapter and quality trimming. Bowtie2 v2.2.1 was used to remove reads that aligned to the hg38 human reference genome, and all remaining reads were mapped to a custom database that included all bacterial and archaeal whole-genome shotgun assemblies available at NCBI as of March 2015. For the bacterial and archaeal reads, the highest-identity match was chosen. If there were multiple top hits, the lowest common ancestor was determined. Taxonomic abundances in the form of read counts were normalized based on the average genome length per species bucket. Using KEGG release 73.1, reads whose genomic coordinates overlapped known KEGG orthologs (K numbers) were tabulated. Coding sequences from reference genomes that have not been specifically annotated by KEGG were aligned to all known KEGG orthologs. Any coding sequence that had >70% identity and >70% query coverage with respect to a known KEGG ortholog was assigned to that KEGG ortholog to create links between new genomes and entries in the KEGG database (termed “k-genes” in this paper). KEGG modules (M numbers) were calculated stepwise and identified as complete if 65% of the reaction steps were present per detected species and for the metagenome as a whole. Pathways were constructed for each taxon and metagenome by calculating the minimum set through MinPath resulting from presence of the gene orthologs. Pipeline code can be found at the following Web location: https://github.com/cmmr/puma-deprecated.
For the 14 of 135 sample duplicates, we selected one duplicate at random for the analytic sample. Alpha diversity measures (observed species/k-genes and Shannon index value for species/k-genes) were calculated using the “estimate_richness” function in the Phyloseq R package (35). Then, on the basis of the rarefaction curves for alpha diversity, we rarefied each sample to 2,000,000 reads, eliminating six samples from our analysis (a FIT tube sample frozen day-4, a no-solution sample frozen day-0, one 95% ethanol sample frozen day-0 and two frozen day-4, and a FOBT card sample frozen day-0). Beta diversity measures were calculated based on Bray-Curtis and Jaccard distance matrices generated separately from the composition of estimated species and k-genes using the vegan R package (36). Alpha and beta diversity estimates presented for subsequent analyses were based on rarefied data.
Statistical analyses.
Statistical analyses were conducted using R, version 3.5.2, and SAS, version 9.4 (SAS Institute, Inc.). To identify possible outliers and check for sample mishandling/misclassification, we performed calculation using the Partitioning Around Medoids algorithm based on Jaccard and Bray-Curtis distance with the number of clusters set to 15 (the number of subjects), but all samples clustered by subject.
We tested for differences in alpha diversity (observed species/k-genes and the Shannon diversity index for species/k-genes) between collection methods by calculating least-squares means of the alpha diversity metrics using mixed-effects models, adjusted for time at ambient temperature, for each collection method. We considered samples without solution frozen immediately to represent the referent group.
We estimated the percentage of variability (R2) explained by subject, collection method, and day of freezing based on the Bray-Curtis and Jaccard distance matrices using the Adonis function in the vegan package in R to perform permutational multivariate analysis of variance (36).
We calculated intraclass correlation coefficients (ICCs) to evaluate stability and concordance using a mixed-effects model with a random intercept for subject and fixed effects for freezing on day-0 or day-4 (stability) or for collection method (concordance). We calculated ICCs based on the three most abundant phyla (square root transformed), observed species/k-genes, the Shannon index value for species/k-genes, and the top two principal-coordinate vectors of Bray-Curtis and Jaccard distance matrices for species composition. We also calculated the ICCs for the square root-transformed relative abundance of the top 20 most abundant species and k-genes and of the top 10 most abundant modules and pathways present in >50% of fecal samples. To calculate ICCs for stability at ambient temperature, for each fecal collection method, we compared one sample replicate frozen on day-0 to one frozen on day-4 for each participant. To calculate ICCs for concordance, we compared one replicate of samples without solution frozen day-0 (the putative “gold standard”) to one replicate from each of the other collection methods frozen day-0 for each participant. We calculated 95% confidence intervals using the bootstrap-technique to resample the study population with replacement over 1,000 iterations. We interpreted ICC values of <40% as representing a poor outcome and ICC values of ≥75% as representing an excellent outcome (37).
To assess the sensitivity of our stability and concordance estimates to various assumptions, we (i) calculated Spearman correlations (SCCs) to assess concordance and to compare the rank order of the metagenomic metrics to the “gold standard”; (ii) repeated our phylum, species, k-gene, module, and pathway analyses addressing the compositional nature of microbial data by using centered log ratio transformations, described previously (31); (iii) repeated the phylum, species, k-gene, module, and pathway analyses using untransformed relative abundances; and (iv) calculated concordance ICCs for the microbiome metrics for each pairwise comparison of the collection methods (e.g., for FOBT cards versus RNAlater).
Data availability.
The data determined in this work are available in the National Center for Biotechnology (NCBI) Sequence Read Archive under accession number PRJNA606198.
ACKNOWLEDGMENTS
This work was supported by the Intramural Research Program of the National Cancer Institute at the National Institutes of Health and by grants from the National Institutes of Health (1R01CA179243 to N.C.; P42ES10349 for the Center for Individualized Medicine at the Mayo Clinic [to J.C.]).
We declare that we have no potential conflicts of interest.
REFERENCES
- 1.Komaroff AL. 2018. The microbiome and risk for atherosclerosis. JAMA 319:2381–2382. doi: 10.1001/jama.2018.5240. [DOI] [PubMed] [Google Scholar]
- 2.Tilg H, Adolph TE, Gerner RR, Moschen AR. 2018. The intestinal microbiota in colorectal cancer. Cancer Cell 33:954–964. doi: 10.1016/j.ccell.2018.03.004. [DOI] [PubMed] [Google Scholar]
- 3.Wang X, Yang Y, Huycke MM. 2017. Microbiome-driven carcinogenesis in colorectal cancer: models and mechanisms. Free Radic Biol Med 105:3–15. doi: 10.1016/j.freeradbiomed.2016.10.504. [DOI] [PubMed] [Google Scholar]
- 4.Kostic AD, Chun E, Meyerson M, Garrett WS. 2013. Microbes and inflammation in colorectal cancer. Cancer Immunol Res 1:150–157. doi: 10.1158/2326-6066.CIR-13-0101. [DOI] [PubMed] [Google Scholar]
- 5.Vogtmann E, Hua X, Zeller G, Sunagawa S, Voigt AY, Hercog R, Goedert JJ, Shi J, Bork P, Sinha R. 2016. colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing. PLoS One 11:e0155362. doi: 10.1371/journal.pone.0155362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L. 2013. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 105:1907–1911. doi: 10.1093/jnci/djt300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Robinson C, Brotman R, Ravel J. 2016. Intricacies of assessing the human microbiome in epidemiological studies. Ann Epidemiol 26:311–321. doi: 10.1016/j.annepidem.2016.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Vandeputte D, Tito RY, Vanleeuwen R, Falony G, Raes J. 2017. Practical considerations for large-scale gut microbiome studies. FEMS Microbiol Rev 41:S154–S167. doi: 10.1093/femsre/fux027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Vogtmann E, Hua X, Zhou L, Wan Y, Suman S, Zhu B, Dagnall CL, Hutchinson A, Jones K, Hicks BD, Sinha R, Shi J, Abnet CC. 2018. Temporal variability of oral microbiota over 10 months and the implications for future epidemiologic studies. Cancer Epidemiol Biomarkers Prev 27:594–600. doi: 10.1158/1055-9965.EPI-17-1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sinha R, Chen J, Amir A, Vogtmann E, Shi J, Inman KS, Flores R, Sampson J, Knight R, Chia N. 2016. Collecting fecal samples for microbiome analyses in epidemiology studies. Cancer Epidemiol Biomarkers Prev 25:407–416. doi: 10.1158/1055-9965.EPI-15-0951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Vogtmann E, Chen J, Amir A, Shi J, Abnet CC, Nelson H, Knight R, Chia N, Sinha R. 2017. Comparison of collection methods for fecal samples in microbiome studies. Am J Epidemiol 185:115–123. doi: 10.1093/aje/kww177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Vogtmann E, Chen J, Kibriya MG, Chen Y, Islam T, Eunes M, Ahmed A, Naher J, Rahman A, Amir A, Shi J, Abnet CC, Nelson H, Knight R, Chia N, Ahsan H, Sinha R. 2017. Comparison of fecal collection methods for microbiota studies in Bangladesh. Appl Environ Microbiol 83:e00361-17. doi: 10.1128/AEM.00361-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207–214. doi: 10.1038/nature11234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Aagaard K, Petrosino J, Keitel W, Watson M, Katancik J, Garcia N, Patel S, Cutting M, Madden T, Hamilton H, Harris E, Gevers D, Simone G, McInnes P, Versalovic J. 2013. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J 27:1012–1022. doi: 10.1096/fj.12-220806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Fu BC, Randolph TW, Lim U, Monroe KR, Cheng I, Wilkens LR, Le Marchand L, Hullar MAJ, Lampe JW. 2016. Characterization of the gut microbiome in epidemiologic studies: the multiethnic cohort experience. Ann Epidemiol 26:373–379. doi: 10.1016/j.annepidem.2016.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.McInnes P, Cutting M. 2010. Manual of procedures for Human Microbiome Project, V 12.0. https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetPdf.cgi?id=phd003190.2.
- 17.Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL. 2016. Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun 469:967–977. doi: 10.1016/j.bbrc.2015.12.083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tessler M, Neumann JS, Afshinnekoo E, Pineda M, Hersch R, Velho LFM, Segovia BT, Lansac-Toha FA, Lemke M, DeSalle R, Mason CE, Brugler MR. 2017. Large-scale differences in microbial biodiversity discovery between 16S amplicon and shotgun sequencing. Sci Rep 7:6589. doi: 10.1038/s41598-017-06665-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto J-M, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, et al. . 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65. doi: 10.1038/nature08821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, Earl AM, Giannoukos G, Boylan MR, Ciulla D, Gevers D, Izard J, Garrett WS, Chan AT, Huttenhower C. 2014. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci U S A 111:E2329–E2338. doi: 10.1073/pnas.1319284111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wang Z, Zolnik CP, Qiu Y, Usyk M, Wang T, Strickler HD, Isasi CR, Kaplan RC, Kurland IJ, Qi Q, Burk RD. 28 August 2018, posting date Comparison of fecal collection methods for microbiome and metabolomics studies. Front Cell Infect Microbiol doi: 10.3389/fcimb.2018.00301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Song SJ, Amir A, Metcalf JL, Amato KR, Xu ZZ, Humphrey G, Knight R. 2016. Preservation methods differ in fecal microbiome stability, affecting suitability for field studies. mSystems 1:e00021-16. doi: 10.1128/mSystems.00021-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dominianni C, Wu J, Hayes RB, Ahn J. 2014. Comparison of methods for fecal microbiome biospecimen collection. BMC Microbiol 14:103. doi: 10.1186/1471-2180-14-103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Rounge TB, Meisal R, Nordby JI, Ambur OH, de Lange T, Hoff G. 2018. Evaluating gut microbiota profiles from archived fecal samples. BMC Gastroenterol 18:171. doi: 10.1186/s12876-018-0896-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Fu BC, Randolph TW, Lim U, Monroe KR, Cheng I, Wilkens LR, Le Marchand L, Lampe JW, Hullar M. 2019. Temporal variability and stability of the fecal microbiome: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 28:154–162. doi: 10.1158/1055-9965.EPI-18-0348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Amir A, McDonald D, Navas-Molina JA, Debelius J, Morton JT, Hyde E, Robbins-Pianka A, Knight R. 2017. Correcting for microbial blooms in fecal samples during room-temperature shipping. mSystems 2:e00199-16. doi: 10.1128/mSystems.00199-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Choo JM, Leong LEX, Rogers GB. 2015. Sample storage conditions significantly influence faecal microbiome profiles. Sci Rep 5:16350–16310. doi: 10.1038/srep16350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Bundgaard-Nielsen C, Hagstrøm S, Sørensen S. 2018. Interpersonal variations in gut microbiota profiles supersedes the effects of differing fecal storage conditions. Sci Rep 8:17367. doi: 10.1038/s41598-018-35843-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Roesch LFW, Casella G, Simell O, Krischer J, Wasserfall CH, Schatz D, Atkinson MA, Neu J, Triplett EW. 2009. Influence of fecal sample storage on bacterial community diversity. Open Microbiol J 3:40–46. doi: 10.2174/1874285800903010040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Bahl MI, Bergström A, Licht TR. 2012. Freezing fecal samples prior to DNA extraction affects the Firmicutes to Bacteroidetes ratio determined by downstream quantitative PCR analysis. FEMS Microbiol Lett 329:193–197. doi: 10.1111/j.1574-6968.2012.02523.x. [DOI] [PubMed] [Google Scholar]
- 31.Gloor GB, Wu JR, Pawlowsky-Glahn V, Egozcue JJ. 2016. It’s all relative: analyzing microbiome data as compositions. Ann Epidemiol 26:322–329. doi: 10.1016/j.annepidem.2016.03.003. [DOI] [PubMed] [Google Scholar]
- 32.Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R. 2016. Comparison of collection methods for fecal samples for discovery metabolomics in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 25:1483–1490. doi: 10.1158/1055-9965.EPI-16-0409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Flores R, Shi J, Yu G, Ma B, Ravel J, Goedert JJ, Sinha R. 2015. Collection media and delayed freezing effects on microbial composition of human stool. Microbiome 3:33. doi: 10.1186/s40168-015-0092-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Voigt AY, Costea PI, Kultima JR, Li SS, Zeller G, Sunagawa S, Bork P. 2015. Temporal and technical variability of human gut metagenomes. Genome Biol 16:73. doi: 10.1186/s13059-015-0639-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.McMurdie PJ, Holmes S. 2013. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8:e61217. doi: 10.1371/journal.pone.0061217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Oksanen J, Blanchet FG, Friendly M, Kindt R, Legendre P, Mcglinn D, Minchin PR, O ‘Hara RB, Simpson GL, Solymos P, Henry M, Stevens H, Szoecs E, Wagner H, Oksanen MJ. 2017. Package “vegan”: community ecology package 2.4.3. https://github.com/vegandevs/vegan/issues. Accessed 21 July 2017.
- 37.Rosner B. 2016. Fundamentals of biostatistics, 8th ed Cengage Learning, Boston, MA. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data determined in this work are available in the National Center for Biotechnology (NCBI) Sequence Read Archive under accession number PRJNA606198.